13F-HR filed by Birchview Capital, LP
Birchview Capital, LP filed this 13F-HR for the quarter ended 2023-09-30, filed 2023-11-14, with 51 holding rows worth $117,495,182.
- Accession
- 0001618205-23-000005
- Filer
- CIK 1618205
- Filed
- 2023-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2023
A holdings report, 52 entries on the cover page, a total value of $117,495,182 stated on the cover page (in dollars after the unit check, H1), rows summing to $117,495,182 with VALUE read as dollars as filed, 13F file number 028-16416. A later restatement replaced it, so the quarter does not use it. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Bristol-Myers Squibb Company | 110122108 | COM | 716,297 | $41,573,898 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 77,240 | $8,689,500 | dollars as filed | |
| BIODESIX INC | 09075X108 | COM | 5,193,336 | $8,527,159 | dollars as filed | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 169,574 | $8,181,946 | dollars as filed | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 240,400 | $5,009,936 | dollars as filed | |
| QUIDEL CORP | 74838J101 | COM | 65,203 | $4,762,427 | dollars as filed | |
| OVINTIV INC | 69047Q102 | COM | 84,200 | $4,005,394 | dollars as filed | |
| IMMUNOGEN INC | 45253H101 | COMMON STOCK | 190,000 | $3,015,300 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 11,000 | $2,484,570 | dollars as filed | |
| ELUTIA INC | 05479K106 | CL A COM | 1,655,184 | $2,366,913 | dollars as filed | |
| HARROW INC | 415858109 | COM | 150,000 | $2,155,500 | dollars as filed | |
| PHREESIA INC | 71944F106 | COM | 82,700 | $1,544,836 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 50,000 | $1,400,500 | dollars as filed | |
| BLUEBIRD BIO INC | 09609G100 | COM | 455,200 | $1,383,808 | dollars as filed | |
| CORCEPT THERAPEUTICS INC | 218352102 | COM | 50,000 | $1,362,250 | dollars as filed | |
| MASIMO CORP COM | 574795100 | Stock | 15,280 | $1,339,750 | dollars as filed | |
| FOGHORN THERAPEUTICS INC | 344174107 | COMMON STOCK | 264,843 | $1,324,215 | dollars as filed | |
| Accelerate Diagnostics | 00430H102 | COM | 225,239 | $1,295,123 | dollars as filed | |
| INHIBRX INC | 45720L107 | COM | 70,448 | $1,292,721 | dollars as filed | |
| EQUITRANS MIDSTREAM CORP NPV | 294600101 | COM | 133,050 | $1,246,679 | dollars as filed | |
| ALPHATEC HLDGS INC | 02081G201 | COM NEW | 80,000 | $1,037,600 | dollars as filed | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 26,400 | $916,872 | dollars as filed | |
| PIONEER NATURAL RESOURCES CO | 723787107 | COM | 3,800 | $872,290 | dollars as filed | |
| 10X GENOMICS INC CL A COM | 88025U109 | Stock | 21,000 | $866,250 | dollars as filed | |
| AXOGEN INC | 05463X106 | COM | 173,000 | $865,000 | dollars as filed | |
| KARYOPHARM THERAPEUTICS INC | 48576U106 | COM | 571,832 | $766,255 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 25,000 | $736,500 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422G107 | COM | 82,000 | $733,080 | dollars as filed | |
| DOCGO INC | 256086109 | COM | 130,000 | $692,900 | dollars as filed | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 18,000 | $684,720 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 38,000 | $633,840 | dollars as filed | |
| SILK ROAD MEDICAL INC | 82710M100 | COMMON STOCK | 41,294 | $618,997 | dollars as filed | |
| PROGYNY INC COM | 74340E103 | Stock | 18,000 | $612,360 | dollars as filed | |
| KINIKSA PHARMACEUTICALS LTD | G5269C101 | COM CL A | 30,000 | $521,100 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 40,000 | $385,200 | dollars as filed | |
| HALOZYME THERAPEUTICS INC COM | 40637H109 | Stock | 10,000 | $382,000 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 10,000 | $341,600 | dollars as filed | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 28,000 | $340,480 | dollars as filed | |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 85,000 | $334,900 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 2,500 | $303,050 | dollars as filed | |
| ARVINAS INC | 04335A105 | COM | 15,000 | $294,600 | dollars as filed | |
| XENCOR INC | 98401F105 | COMMON STOCK | 12,300 | $247,845 | dollars as filed | |
| 2SEVENTY BIO INC COMMON STOCK | 901384107 | Stock | 59,833 | $234,545 | dollars as filed | |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 25,114 | $227,282 | dollars as filed | |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 7,000 | $223,160 | dollars as filed | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 209,088 | $174,128 | dollars as filed | |
| G1 THERAPEUTICS INC | 3621LQ109 | COM | 120,000 | $172,800 | dollars as filed | |
| Inflarx Nv | N44821101 | COM | 50,000 | $149,000 | dollars as filed | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 20,000 | $141,600 | dollars as filed | |
| NEKTAR THERAPEUTICS | 640268108 | COM | 28,000 | $16,677 | dollars as filed | |
| YIELD10 BIOSCIENCE INC | 98585K102 | COM | 18,750 | $6,126 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001618205-23-000005 | this filing | 2023-11-14 | acceptance time not in the bulk data set | |
| 13F-HR/A 0001618205-25-000003 | base | 2025-06-30 | acceptance time not in the bulk data set |